Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InfraDure Biopump in Relapsing Hepatitis C
NCT01430000Phase 2Withdrawn
- Sponsor
- Aevi Genomic Medicine
- Modality
- Gene Editing, Gene Silencing, Gene Addition/Replacement
- Countries
- 1
01
Overview
A Phase 2 trial of Infradure in hepatitis C (HCV), sponsored by Aevi Genomic Medicine. Status: withdrawn.
02
Drugs
Infradure
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01430000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430000.